Joshua W. Wang (United States of America)
PathoVax LLC .Presenter of 1 Presentation
Oral Session 4: Vaccines and New Treatment Approaches
Hall D
TOWARDS A CGMP-GRADE CHIMERIC PAPILLOMAVIRUS VACCINE: PROTECTION OVER ONE YEAR OF HPV16 RG-1 VLP COMPARED TO A GARDASIL-9 VACCINATION IN PRE-CLINICAL PAPILLOMAVIRUS ANIMAL MODELS (ID 437)
Session Date
07/22/2020
Session Time
08:45 - 10:15
Room
Hall D
Session Type
Basic Science Oral Session
Lecture Time
09:12 - 09:24
Authors
- Jiafen Hu (United States of America)
- Karla Balogh (United States of America)
- Ken Matsui (United States of America)
- Huimin Tan (United States of America)
- Pola Olczak (United States of America)
- George Buchman (United States of America)
- Brian P. Howard (United States of America)
- Jonathan White (United States of America)
- Michelle Kennedy (United States of America)
- Daniel Boring (United States of America)
- Elizabeth Glaze (United States of America)
- Shizuko Sei (United States of America)
- Ligia A. Pinto (United States of America)
- Sarah Brendle (United States of America)
- Christina Schellenbacher (Austria)
- Neil Christensen (United States of America)
- Reinhard Kirnbauer (Austria)
- Richard Roden (United States of America)
- Robert Shoemaker (United States of America)
- Joshua W. Wang (United States of America)